Multidrug-resistant tuberculosis in Uzbekistan: results
نویسندگان
چکیده
D J Ulmasova1, G Uzakova2, M N Tillyashayhov3, L Turaev4, W van Gemert5, H Hoffmann6, M Zignol5, K Kremer7, T Gombogaram8, J Gadoev8, P du Cros9, N Muslimova4, A Jalolov2, A Dadu7, P de Colombani7, O Telnov10, A Slizkiy10, B Kholikulov1, M Dara7, D Falzon ([email protected])5 1. Republican DOTS Centre, Tashkent, Uzbekistan 2. Programme Implementation Unit, The Global Fund to Fight AIDS, TB and Malaria (TGF), Tashkent, Uzbekistan 3. National Institute of TB and Pulmonology, Tashkent, Uzbekistan 4. National Reference Laboratory (NRL), Tashkent, Uzbekistan 5. World Health Organization, Global TB Programme, Geneva, Switzerland 6. Supranational TB Reference Laboratory (SRL Gauting), IML red GmbH, synlab Bayern, Asklepios Fachkliniken MünchenGauting, Germany 7. World Health Organization Regional Office for Europe, Copenhagen, Denmark 8. World Health Organization Country Office, Tashkent, Uzbekistan 9. Médecins Sans Frontières (MSF), London, United Kingdom 10. Médecins Sans Frontières (MSF), Tashkent/Nukus, Uzbekistan
منابع مشابه
Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011.
Multidrug-resistant tuberculosis (MDR-TB; resistance to at least rifampicin and isoniazid) is a global public health concern. In 2010–2011, Uzbekistan, in central Asia, conducted its first countrywide survey to determine the prevalence of MDR-TB among TB patients. The proportion of MDR-TB among new and previously treated TB patients throughout the country was measured and risk factors for MDR-T...
متن کاملMultidrug-resistant Tuberculosis in Central Asia
Multidrug-resistant tuberculosis (MDR-TB) has emerged as a major threat to TB control, particularly in the former Soviet Union. To determine levels of drug resistance within a directly observed treatment strategy (DOTS) program supported by Médecins Sans Frontières in two regions in Uzbekistan and Turkmenistan, Central Asia, we conducted a cross-sectional survey of smear-positive TB patients in...
متن کاملDifferential protein expression in Mycobacterium tuberculosis susceptible and multidrug resistant isolates
Introduction: Infections by multidrug resistant Mycobacterium tuberculosis (MDR-TB) is a major public health challenge. Secretion of proteins by M. tuberculosis plays an important role in the pathogenesis of the bacterium. We compared the protein profiles of susceptible M. tuberculosis and MDR-TB isolates using proteomic analyses, namely two dimensional gel electrophoresis (2DE) and mass spectr...
متن کاملWHO recommendations for multidrug-resistant tuberculosis.
2234 www.thelancet.com Vol 388 November 5, 2016 3 Casas EC. Experiences with short MDR-TB regimen in unstable settings. The 46th Union World Conference on Lung Health; Cape Town, South Africa; Dec 2–6, 2015. http://capetown. worldlunghealth.org/programme/ programme-by-type/sponsored-satellitesymposia/pdf/12-Sponsored-satellitesymposium.pdf (accessed June 18, 2016). 4 Casas E, Gashu T, Greig J, ...
متن کاملIL-10 and IL-12 Production in Response to Mycobacterium Tuberculosis Total Lipid Antigens in Multidrug-Resistant Tuberculosis
Background: Mycobacterium tuberculosis lipid antigens take part in pathogenicity of the bacterium but the response of monocytes/macrophages to these antigens in tubercu-losis is not well known. Objective: The aim of current investigation was to study the M. tuberculosis lipid antigens in tuberculosis pathogenesis. Methods: In the present study M. tuberculosis lipid antigens were extracted. Mono...
متن کامل